Heleen Marynissen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Contrast Enhanced Ultrasound

Induced Pluripotent Stem Cells

Top Venues

Journal of inflammation research

Clinical and translational science

British journal of clinical pharmacology

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Heleen Marynissen, Jan de Hoon
Glucocorticoids Do Not Affect the Vascular Component of TRP-Mediated Neurogenic Skin Inflammation. Journal of inflammation research 17 (2024)
Heleen Marynissen, Jan de Hoon
Glucocorticoids Do Not Affect the Vascular Component of TRP-Mediated Neurogenic Skin Inflammation. Journal of inflammation research 17 (2024)
Dorien Bamps, Anthony James Blockeel, Erwin Dreesen, Heleen Marynissen, Jolien Laenen, Anne Van Hecken, August Wilke, Shahram Shahabi, Kirk W Johnson, Emily Catherine Collins, Lisa M Broad, Keith G Phillips, Jan de Hoon
TRPA1 antagonist LY3526318 inhibits the cinnamaldehyde-evoked dermal blood flow increase: translational proof of pharmacology. Clinical pharmacology and therapeutics (2023)
Heleen Marynissen, Delphine Mergaerts, Dorien Bamps, Jan de Hoon
Does etodolac affect TRPA1 functionality in vivo in human? Journal of basic and clinical physiology and pharmacology (2023)
Heleen Marynissen, Linde Buntinx, Dorien Bamps, Marleen Depre, Els Ampe, Anne Van Hecken, Kristin Gabriel, Steve Sands, Gabriel Vargas, Jan de Hoon
First-in-human development of a pharmacodynamic biomarker for PAC 1 receptor antagonists using intradermal injections of maxadilan. Clinical and translational science 15 (8) (2022)
Heleen Marynissen, Thomas Lodeweyckx, Didier Bielen, Jan N de Hoon
Doppler ultrasound to assess the pharmacodynamic effects of splanchnic vasoactive compounds. British journal of clinical pharmacology (2021)